Current pharmaceutical biotechnology | 2021

Sulfated extract of Abelmoschus esculentus: A potential cancer chemopreventive agent.

 
 
 
 
 
 

Abstract


BACKGROUND\nAbelmoschus esculentus (AE) (okra), is an edible plant used in many food applications.\n\n\nOBJECTIVE\nThis study explored whether sulfated AE (SAE) has promising cancer chemopreventive activities that may recommend it as a functional food supplement \u200einstead of (or in addition to) AE for the population at risk of cancer and in the health food industry.\n\n\nMETHODS\nCytochrome P450-1A (CYP1A)\u200e was estimated by fluorescence enzymatic reaction, using β-naphthoflavone-treated cells (CYP1A inducer). Peroxyl and hydroxyl radical scavenging was assayed by an oxygen radical absorbance capacity assay. Flow cytometry was used to analyze apoptosis/necrosis in MCF-7 cells, cell cycle phases in MCF-7 cells, and macrophage binding to fluorescein isothiocyanate-lipopolysaccharide (FITC-LPS)\u200e. Nitric oxide was determined by Griess assay in LPS-stimulated macrophages, and cytotoxicity was determined by MTT assay. Diethylnitrosamine (DEN) was used to induce hepatic tumor initiation in rats. Placental glutathione-S-transferase (GSTP; an initiation marker) was stained in a fluorescence immunohistochemical analysis of liver sections, and histopathological changes were examined.\n\n\nRESULTS\nSAE exhibited strong antitumor initiation and antitumor promotion activities. It suppressed CYP1A, \u200escavenged peroxyl and hydroxyl radicals, induced macrophage proliferation, suppressed \u200emacrophage binding to FITC-LPS, inhibited nitric oxide generation, showed specific cytotoxicity to \u200ehuman breast MCF-7 adenocarcinoma cells, and disturbed the cell cycle phases (S and G2/M phases) \u200ein association with an increased percentage of apoptotic/necrotic MCF-7 cells. Over a short time period, DEN stimulated liver cancer initiation, but SAE treatment reduced the DEN-induced histopathological alterations and \u200einhibited CYP1A and GSTP.\n\n\nCONCLUSION\nSAE extract has the potential for use as an alternative to AE in health foods to provide cancer chemoprevention in populations at risk for cancer.

Volume None
Pages None
DOI 10.2174/1389201022666210714151419
Language English
Journal Current pharmaceutical biotechnology

Full Text